Chitosan as a Functional Carrier for the Local Delivery Anti-Inflammatory Systems Containing Scutellariae baicalensis radix Extract
- PMID: 36297583
- PMCID: PMC9611887
- DOI: 10.3390/pharmaceutics14102148
Chitosan as a Functional Carrier for the Local Delivery Anti-Inflammatory Systems Containing Scutellariae baicalensis radix Extract
Abstract
The aim of the study was to establish the influence of chitosan on the preparation of systems containing Scutellariae baicalensis radix extract and to demonstrate the potential of anti-inflammatory action for the treatment of periodontitis. In the first stage, the impact of the variables (extraction mixture composition, temperature, and the number of extraction cycles) on the extracted samples' biological characteristics was analyzed using the Design of Experiments (DoE) approach. The best conditions for baicalin, baicalein, and wogonin extraction from Scutellariae baicalensis radix were 80% methanol in the extraction mixture, 70 °C, and 4 cycles per 60 min. The DoE approach can be used to choose the best chitosan system parameters with equal success. An increase in the deacetylation degree of chitosan used in the system improved the potential for reducing free radicals and inhibiting the hyaluronidase enzyme. Also, increasing the degree of chitosan deacetylation results in increased resistance of the carrier to biodegradation and an extended baicalin release profile, which is also associated with an increase in the viscosity of the chitosan-based system. In total, the system of a freeze-dried extract with chitosan 90/500 in the ratio of 2:1 (system S9) turns out to be the one with the best physicochemical (high percentage of baicalin release and the highest viscosity conditioning the prolonged stay at the site of administration) and biological properties (the highest antioxidant and anti-inflammatory activities), resulting in the highest potential for use in the treatment of oral inflammatory diseases.
Keywords: Scutellariae baicalensis radix; anti-hyaluronidase activity; antioxidant activity; chitosan.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- PMC Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications. [(accessed on 28 August 2022)]; Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557018/
-
- PMC Biomedical Applications of Chitosan and Its Derivative Nanoparticles. [(accessed on 28 August 2022)]; Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415442/
-
- PMC Chitosan-Based Nanomaterials for Drug Delivery. [(accessed on 28 August 2022)]; Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222903/
-
- Frontiers Chitosan-Based Functional Materials for Skin Wound Repair: Mechanisms and Applications. [(accessed on 28 August 2022)]. Available online: https://www.frontiersin.org/articles/10.3389/fbioe.2021.650598/full. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
